Impact of obesity in children with narcolepsy

CNS Neuroscience and Therapeutics

Volumn 19, Issue 7, 2013, Pages 521-528

  Inocente, Clara Odilia ^a   Lavault, Sophie ^b,c   Lecendreux, Michel ^b,d   Dauvilliers, Yves ^b,e   Reimao, Rubens ^f   Gustin, Marie Paule ^a,g   Castets, Sarah ^h   Spiegel, Karine ^a   Lin, Jian Sheng ^a   Arnulf, Isabelle ^b,c   Franco, Patricia ^a,b  

^a UNIVERSITÉ LYON 1   (France)

^b National Reference Centre for Orphan Diseases Narcolepsy Idiopathic hypersomnia and Kleine Levin Syndrome (CNR Narcolepsie Hypersomnie)   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d HÔPITAL ROBERT DEBRÉ   (France)

^e GUI DE CHAULIAC HOSPITAL   (France)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

^g HOSPICES CIVILS DE LYON   (France)

^h GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Child; Narcolepsy; Obesity; Sleep

Indexed keywords

ADOLESCENT; ALERTNESS; ANTHROPOMETRY; APNEA HYPOPNEA INDEX; AROUSAL; ARTICLE; BODY MASS; BRAIN ELECTROPHYSIOLOGY; CATAPLEXY; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FATIGUE; FEMALE; HISTORY; HUMAN; HYPERACTIVITY; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; MOOD; NARCOLEPSY; OBESITY; ONSET AGE; PRESCHOOL CHILD; QUALITY OF LIFE; QUESTIONNAIRE; SCHOOL CHILD; SLEEP QUALITY; SOMNOLENCE;

ADOLESCENT; AFFECT; ANTHROPOMETRY; AROUSAL; BODY MASS INDEX; CATAPLEXY; CHILD; CHILD, PRESCHOOL; EDUCATIONAL STATUS; FEMALE; HUMANS; HYPERKINESIS; MALE; NARCOLEPSY; OBESITY; POLYSOMNOGRAPHY; QUALITY OF LIFE; QUESTIONNAIRES; SLEEP; SLEEP DISORDERS;

EID: 84879007507     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12105     Document Type: Article

References (59)

1. American Academy of Sleep Medicine. The International Classification of Sleep Disorders, 2nd edn. Westchester, Illinois: American Academy of Sleep Medicine, 2005; 83-92.
2. Nevsimalova S, Buskova J, Kemlink D, Sonka K, Skibova J. Does age at the onset of narcolepsy influence the course and severity of the disease? Sleep Med 2009;10:967-972.
3. Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000;6:991-997.
4. Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000;27:469-474.
5. Cvetkovic-Lopes V, Bayer L, Dorsaz S, et al. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. J Clin Invest 2010;120:713-719.
6. van den Pol AN, Gao XB, Obrietan K, Kilduff TS, Belousov AB. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J Neurosci 1998;18:7962-7971.
7. Rolls A, Schaich Borg J, de Lecea L. Sleep and metabolism: Role of hypothalamic neuronal circuitry. Best Pract Res Clin Endocrinol Metab 2010;24:817-828.
8. Sakurai T, Mieda M. Connectomics of orexin-producing neurons: Interface of systems of emotion, energy homeostasis and arousal. Trends Pharmacol Sci 2011;32:451-462.
9. Schuld A, Hebebrand J, Geller F, Pollmacher T. Increased body-mass index in patients with narcolepsy. Lancet 2000;355:1274-1275.
10. Dahmen N, Tonn P, Messroghli L, Ghezel-Ahmadi D, Engel A. Basal metabolic rate in narcoleptic patients. Sleep 2009;32:962-964.
11. Kotagal S, Krahn L, Slocumb N. A putative link between childhood narcolepsy and obesity. Sleep Med 2004;5:147-150.
12. Aran A, Einen M, Lin L, Plazzi G, Nishino S, Mignot E. Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: A retrospective study of 51 children. Sleep 2010;33:1457-1464.
13. Peraita-Adrados R, Garcia-Penas J, Ruiz-Falco L, et al. Clinical, polysomnographic and laboratory characteristics of narcolepsy-cataplexy in a sample of children and adolescents. Sleep Med 2011;12:24-27.
14. Snow A, Gozal E, Malhotra A, et al. Severe hypersomnolence after pituitary/hypothalamic surgery in adolescents: Clinical characteristics and potential mechanisms. Pediatrics 2002;110:e74.
15. Drake C, Nickel C, Burduvali E, Roth T, Jefferson C, Pietro B. The pediatric daytime sleepiness scale (PDSS): Sleep habits and school outcomes in middle-school children. Sleep 2003;26:455-458.
16. Murali H, Kotagal S. Off-label treatment of severe childhood narcolepsy-cataplexy with sodium oxybate. Sleep 2006;29:1025-1029.
17. Kovacs M. The Children's Depression, Inventory (CDI). Psychopharmacol Bull 1985;21:995-998.
18. van Beek Y, Hessen DJ, Hutteman R, Verhulp EE, van Leuven M. Age and gender differences in depression across adolescence: Real or 'bias'? J Child Psychol Psychiatry 2012;53:973-985.
19. Goyette CH, Conners CK, Ulrich RF. Normative data on revised Conners Parent and Teacher Rating Scales. J Abnorm Child Psychol 1978;6:221-236.
20. Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale. J Psychosom Res 1993;37:147-153.
21. Simeoni MC, Auquier P, Antoniotti S, Sapin C, San Marco JL. Validation of a French health-related quality of life instrument for adolescents: The VSP-A. Qual Life Res 2000;9:393-403.
22. Gras D. Santé et qualité de vie des frères et soeurs d'enfants atteints de maladies chroniques. Thesis, Nantes, 2009;29-43. Available at http: //www.idref.fr/140196226. (Last accessed 13 October 2011).
23. Iber C, Quan S, for the Amercian Academy of Sleep Medicine. The AASM manual for the scoring of sleep and associated events: Rules, terminology and technical specifications, 1st edn. Westchester, Illinois: American Academy of Sleep Medicine, 2007.
24. Challamel MJ, Mazzola ME, Nevsimalova S, Cannard C, Louis J, Revol M. Narcolepsy in children. Sleep 1994;17:S17-S20.
25. Arnulf I, Lin L, Zhang J, et al. CSF versus serum leptin in narcolepsy: Is there an effect of hypocretin deficiency? Sleep 2006;29:1017-1024.
26. Rolland-Cachera MF. Childhood obesity: Current definitions and recommendations for their use. Int J Pediatr Obes 2011;6:325-331.
27. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: International survey. BMJ 2000;320:1240-1243.
28. Haute Autorité de santé. Surpoids et Obésité de l'enfant et de l'adolescent (Actualisation des recommandations 2003), 2011; 6-7. Available at: http://www.has-sante.fr/portail/jcms/c_964941/surpoids-et-obesite-de-l-enfant-et-de-l-adolescent-actualisation-des-recommandations-2003.
29. Kaplowitz PB, Oberfield SE. Reexamination of the age limit for defining when puberty is precocious in girls in the United States: Implications for evaluation and treatment. Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society. Pediatrics 1999;104:936-941.
30. Gaudineau A, Ehlinger V, Vayssiere C, Jouret B, Arnaud C, Godeau E. Factors associated with early menarche: Results from the French Health Behaviour in School-aged Children (HBSC) study. BMC Public Health 2010;10:175.
31. Tanner J. Growth at adolescence. 2nd edn. Oxford: Blackwell Publications, 1962.
32. McDonagh MS, Peterson K, Thakurta S, Low A. Drug Class Review: pharmacologic Treatments for Attention Deficit Hyperactivity Disorder: Final Update. Available at http://www.ncbi.nlm.nih.gov/books/NBK84419/, 2011.
33. Deheeger M, Bellisle F, Rolland-Cachera MF. The French longitudinal study of growth and nutrition: Data in adolescent males and females. J Hum Nutr Diet 2002;15:429-438.
34. Nevsimalova S, Jara C, Prihodova I, Kemlink D, Sonka K, Skibova J. Clinical features of childhood narcolepsy. Can cataplexy be foretold? Eur J Paediatr Neurol 2011;15:320-325.
35. Dauvilliers Y, Bazin M, Ondze B, Bera O, Besset A, Billiard M. Severity of narcolepsy among French of different ethnic origins (south of France and Martinique). Sleep 2002;25:50-55.
36. Aran A, Lin L, Nevsimalova S, et al. Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep 2009;32:979-983.
37. Medical Products Agency. A registry based comparative cohort study in four Swedish counties of the risk for narcolepsy after vaccination with Pandemrix - A first and preliminary report: Available at http://wwwlakemedelsverketse/upload/nyheter/ 2012;1-10.
38. Partinen M, Saarenpaa-Heikkila O, Ilveskoski I, et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS ONE 2012;7:e33723.
39. Nevsimalova S, Pisko J, Buskova J, et al. Narcolepsy: Clinical differences and association with other sleep disorders in different age groups. J Neurol 2013;260:767-775.
40. Andlauer O, Moore H, Hong SC, et al. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy. Sleep 2012;35:1247-55F.
41. Middelkoop HA, Lammers GJ, Van Hilten BJ, Ruwhof C, Pijl H, Kamphuisen HA. Circadian distribution of motor activity and immobility in narcolepsy: Assessment with continuous motor activity monitoring. Psychophysiology 1995;32:286-291.
42. Kok SW, Overeem S, Visscher TL, et al. Hypocretin deficiency in narcoleptic humans is associated with abdominal obesity. Obes Res 2003;11:1147-1154.
43. Chabas D, Foulon C, Gonzalez J, et al. Eating disorder and metabolism in narcoleptic patients. Sleep 2007;30:1267-1273.
44. Poli F, Plazzi G, Di Dalmazi G, et al. Body mass index-independent metabolic alterations in narcolepsy with cataplexy. Sleep 2009;32:1491-1497.
45. Lammers GJ, Pijl H, Iestra J, Langius JA, Buunk G, Meinders AE. Spontaneous food choice in narcolepsy. Sleep 1996;19:75-76.
46. Dauvilliers Y. Altered sleep-related blood pressure profile in hypocretin-deficient narcoleptic patients. Sleep 2012;35:453-454.
47. Daniels SR, Arnett DK, Eckel RH, et al. Overweight in children and adolescents: Pathophysiology, consequences, prevention, and treatment. Circulation 2005;111:1999-2012.
48. Redline S, Tishler PV, Schluchter M, Aylor J, Clark K, Graham G. Risk factors for sleep-disordered breathing in children. Associations with obesity, race, and respiratory problems. Am J Respir Crit Care Med 1999;159:1527-1532.
49. Chay OM, Goh A, Abisheganaden J, et al. Obstructive sleep apnea syndrome in obese Singapore children. Pediatr Pulmonol 2000;29:284-290.
50. Silvestri JM, Weese-Mayer DE, Bass MT, Kenny AS, Hauptman SA, Pearsall SM. Polysomnography in obese children with a history of sleep-associated breathing disorders. Pediatr Pulmonol 1993;16:124-129.
51. Ievers-Landis CE, Redline S. Pediatric sleep apnea: Implications of the epidemic of childhood overweight. Am J Respir Crit Care Med 2007;175:436-441.
52. Kohler MJ, Thormaehlen S, Kennedy JD, et al. Differences in the association between obesity and obstructive sleep apnea among children and adolescents. J Clin Sleep Med 2009;5:506-511.
53. Schwimmer JB, Burwinkle TM, Varni JW. Health-related quality of life of severely obese children and adolescents. JAMA 2003;289:1813-1819.
54. Gozal D. Sleep-disordered breathing and school performance in children. Pediatrics 1998;102:616-620.
55. Daniels E, King MA, Smith IE, Shneerson JM. Health-related quality of life in narcolepsy. J Sleep Res 2001;10:75-81.
56. Lavault S, Dauvilliers Y, Drouot X, et al. Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy. Sleep Med 2011;12:550-556.
57. Nittur N, Konofal E, Dauvilliers Y, et al. Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: A long-term chart review. Sleep Med 2012;14:30-36.
58. Lecendreux M, Poli F, Oudiette D, et al. Tolerance and efficacy of sodium oxybate in childhood narcolepsy with cataplexy: A retrospective study. Sleep 2012;35:709-711.
59. Inocente C, Arnulf I, Bastuji H, et al. Pitolisant, an inverse agonist of the histamine H3 receptor: An alternative stimulant for narcolepsy-cataplexy in teenagers with refractory sleepiness. Clin Neuropharmacol 2012;35:55-60.